US meat business to grow human organs from pigs

By Oscar Rousseau contact

- Last updated on GMT

Smithfield Foods wants to be able to make pig-to-human organ transplantation
Smithfield Foods wants to be able to make pig-to-human organ transplantation
Smithfield Foods has set up a bioscience unit to supply pork by-product to the medical sector, with the ultimate goal of selling pig organs for human transplantation.

Smithfield Foods, which claims to be the world’s largest pork producer, wants to take a “leadership position​” in using pig parts for medical uses through its new bioscience division.

The company already sells animal by-products to pharmaceutical and medical sectors that use unwanted pig parts to develop drugs that can treat issues such as indigestion, deep vein thrombosis and thyroid problems.

With the new venture, named Smithfield Bioscience, the company will expand these efforts by exploring how pork by-products can be used to address tissue regeneration. It has openly said it wants to look at making pig organs – such as hearts, lungs and liver – easily transplantable to people.


Our commitment to innovation and sustainability stretches across all aspects of our company,​” said Kenneth Sullivan, president and CEO of Smithfield Foods.

Smithfield Bioscience reflects these same values by finding new uses for by-products that benefit the health and wellbeing of others.​”

The new team will be solely focused on these science-based endeavours and will have little to do with Smithfield’s multi-billion-dollar meat packing empire.

One of the first projects for the new division will be taking part in the Advanced Regenerative Manufacturing Institute (ARMI). The public-private US initiative, funded by the US Department of Defence, set up to find new technologies and manufacturing processes for cells, tissue and organ development.

Smithfield is a longstanding leader in sustainability and renewables, with a broad geographic presence and strong manufacturing expertise,​” said Courtney Stanton, vice-president of the new bioscience division.

With these capabilities, our vertical integration and a reputation for transparency and quality, Smithfield Bioscience is well-positioned to help the US medical and pharmaceutical industry achieve significant, scalable developments in biologics.​”

Related topics: Pork, United States, Industry & Markets

Related news

Show more

Related products

Microbiological safety of raw-fermented sausages

Microbiological safety of raw-fermented sausages

Jungbunzlauer | 18-Feb-2019 | Technical / White Paper

Raw-fermented sausages are prone to the contamination with pathogens such as Salmonella and Listeria. Jungbunzlauer gives a new impetus to the exploration...

From trust grows success

From trust grows success

K+G Wetter | 09-Oct-2017 | Data Sheet

The award winning company Wünsch’s Fleischspezialitäten sets new quality standards for meat products – using machines made by K+G Wetter.

Related suppliers


Insanely sickening and sickeningly insane

Posted by shirley,

this is carrying animal abuse to an unbelievable level and a crime way beyond mass murder. how sick can you be?

Report abuse

seriously warped!

Posted by Laurel,

so, the difference between making thyroid extract and heparin from pigs to enabling transplants of organs from pigs is??
hmm lemme think?
that would be INSERTING HUMAN GENES in Pigs to avoid cross species rejection.
calling those organs BY PRODUCTS is rather "misleading" to say the least
unless Smithfield intend for the main body products to be Eaten?
now that leads to lessons learnt already on CJD and prions from feeding a genus its own

Report abuse

Follow us


View more